3 Results for "

dermatologic inflammatory conditions

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "dermatologic inflammatory conditions" in MCE Product Catalog:

Cat. No.: HY-19443
CAS No.: 299460-62-1
Research Areas:  

Inflammation/Immunology

UCB-35440 is an orally active histamine H1 receptor antagonist and 5-lipoxygenase inhibitor. UCB-35440 can be used for the research of dermatologic inflammatory conditions .
loading...
    loading...
Cat. No.: HY-N18789
CAS No.: 8016-84-0
Category:  

Extract

Target:  

Bacterial

Tagetes oil is an organic essential oil extracted from the Tagetes plant exhibiting inherent anti-inflammatory and antimicrobial attributes. Its employment in the research of diverse skin infections, wounds and dermatological conditions has been extensively recognized.
loading...
    loading...
Cat. No.: HY-L022M
3,237 compounds

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication. First, the risk of failure is lower. Second, the time frame for drug development can be reduced. Third, less investment is needed. Approved drugs have identified bioactivities, good pharmacokinetic characteristics and safety which are suitable for drug repurposing.

MCE owns a unique collection of 3,237 approved compounds which have been completed extensive preclinical and clinical studies and have well-characterized bioactivities, safety and bioavailability properties. The package of this library is 96-well microplate with peelable foil seal, which makes the screening process easier and faster.